These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28974844)

  • 1. Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats.
    Hussain SA; Utba RM; Assumaidaee AM
    Med Arch; 2017 Aug; 71(4):251-255. PubMed ID: 28974844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice.
    Lee KC; Hsieh YC; Yang YY; Chan CC; Huang YH; Lin HC
    Sci Rep; 2016 Jan; 6():18899. PubMed ID: 26732252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of the renin-angiotensin system blockers on nonalcoholic fatty liver disease and insulin resistance in C57BL/6 mice.
    Frantz ED; Penna-de-Carvalho A; Batista Tde M; Aguila MB; Mandarim-de-Lacerda CA
    Metab Syndr Relat Disord; 2014 May; 12(4):191-201. PubMed ID: 24517411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
    Elshazly SM
    Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of Aliskiren and Telmisartan in high fructose diet-induced metabolic syndrome in rats.
    Rabie EM; Heeba GH; Abouzied MM; Khalifa MM
    Eur J Pharmacol; 2015 Aug; 760():145-53. PubMed ID: 25917321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.
    Ragab SM; Abd Elghaffar SKh; El-Metwally TH; Badr G; Mahmoud MH; Omar HM
    Lipids Health Dis; 2015 Jul; 14():83. PubMed ID: 26228038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary cytokine profiles according to the site of blockade of the renin-angiotensin system in nephrectomized rats.
    Baracho NCDV; Silveira KDD; Rocha NP; Cordeiro TM; Feracin V; Pereira RM; Reis MAAD; Teixeira MM; Silva ACSE
    J Bras Nefrol; 2017; 39(2):108-118. PubMed ID: 29069238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of RAAS Inhibition by Aliskiren on Paracetamol-Induced Hepatotoxicity Model in Rats.
    Karcioglu SS; Palabiyik SS; Bayir Y; Karakus E; Mercantepe T; Halici Z; Albayrak A
    J Cell Biochem; 2016 Mar; 117(3):638-46. PubMed ID: 26280784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
    Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azilsartan, aliskiren, and combination antihypertensives utilizing renin-angiotensin-aldosterone system antagonists.
    Lanier G; Sankholkar K; Aronow WS
    Am J Ther; 2014; 21(5):419-35. PubMed ID: 22975662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin-angiotensin system.
    Yan K; Shen Y
    Mol Med Rep; 2017 Oct; 16(4):3965-3973. PubMed ID: 28765966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin.
    Saad ZA; Khodeer DM; Zaitone SA; Ahmed AAM; Moustafa YM
    Life Sci; 2020 Jul; 253():117725. PubMed ID: 32348835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats.
    Gandhi S; Srinivasan B; Akarte AS
    J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):3-13. PubMed ID: 22791702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
    Awad AS; Abd Al Haleem EN; El-Bakly WM; Sherief MA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):381-91. PubMed ID: 26753695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct renin inhibitor prevents and ameliorates insulin resistance, aortic endothelial dysfunction and vascular remodeling in fructose-fed hypertensive rats.
    Chou CL; Pang CY; Lee TJ; Fang TC
    Hypertens Res; 2013 Feb; 36(2):123-8. PubMed ID: 22895064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effect of aliskiren on renal ischemia/reperfusion injury in rats: electron microscopy and molecular study.
    Ziypak T; Halici Z; Alkan E; Akpinar E; Polat B; Adanur S; Cadirci E; Ferah I; Bayir Y; Karakus E; Mercantepe T
    Ren Fail; 2015 Mar; 37(2):343-54. PubMed ID: 25524622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.
    Imanishi T; Tsujioka H; Ikejima H; Kuroi A; Takarada S; Kitabata H; Tanimoto T; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertension; 2008 Sep; 52(3):563-72. PubMed ID: 18645051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats.
    Chou CL; Lin H; Chen JS; Fang TC
    PLoS One; 2017; 12(7):e0180712. PubMed ID: 28700686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
    Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.
    Elrashidy RA; Asker ME; Mohamed HE
    J Pharm Pharmacol; 2012 Jun; 64(6):862-71. PubMed ID: 22571265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.